Nexien BioPharma, Inc. (OTCMKTS:NXEN) Short Interest Update

Nexien BioPharma, Inc. (OTCMKTS:NXEN) was the recipient of a significant increase in short interest during the month of April. As of April 15th, there was short interest totalling 28,900 shares, an increase of 28,800.0% from the March 31st total of 100 shares. Based on an average trading volume of 22,100 shares, the short-interest ratio is presently 1.3 days.

Nexien BioPharma Price Performance

Shares of NXEN opened at $0.02 on Friday. Nexien BioPharma has a 1-year low of $0.01 and a 1-year high of $0.10. The stock has a market cap of $1.13 million, a PE ratio of -1.68 and a beta of 1.60. The firm has a fifty day moving average price of $0.02 and a 200 day moving average price of $0.02.

Nexien BioPharma Company Profile

Nexien BioPharma, Inc focuses on the formulation, development, and commercialization of cannabinoid-based pharmaceuticals, drug delivery systems, and related technologies for diseases, disorders, and medical conditions. The company was formerly known as Intiva BioPharma Inc and changed its name to Nexien BioPharma, Inc in September 2018.